On Monday, the U.S. National Institutes of Health (NIH) announced they had started the first human trial of a possible vaccine for SARS-CoV-2, the coronavirus behind covid-19, with the first test subject receiving their shot that very day. But while this trial, based in Seattle, and other upcoming ones are certainly…
via Gizmodo